Nektar Therapeutics

NKTR

$37.78

Name : Nektar Therapeutics

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,289,922,176.00

EPSttm : -18.96

Nektar Therapeutics

$37.78

0.12%

$0.045

NKTR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

21.17

Margin Of Safety %

Put/Call OI Ratio

0.29

EPS Next Q Diff

-1.53

EPS Last/This Y

1.65

EPS This/Next Y

-2.42

Price

37.79

Target Price

133.08

Analyst Recom

1.53

Performance Q

-50.31

Upside

-330.5%

Beta

1.42

Ticker: NKTR

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	NKTR	39.83	0.27	1.58	56879
2026-10-13	NKTR	37.92	0.26	1.87	56543
2026-10-14	NKTR	36.69	0.25	0.49	56573
2026-10-15	NKTR	37.74	0.25	0.57	56787
2026-10-16	NKTR	35.76	0.22	1.66	56813
2026-10-19	NKTR	36.59	0.32	0.16	37909
2026-10-20	NKTR	39.03	0.31	0.43	39087
2026-10-21	NKTR	38.3	0.31	0.47	39702
2026-10-22	NKTR	38.61	0.31	1.30	40649
2026-10-23	NKTR	37.24	0.31	0.11	40872
2026-10-26	NKTR	37.43	0.31	0.04	41042
2026-10-27	NKTR	37.97	0.31	0.23	41036
2026-10-28	NKTR	38.55	0.31	0.05	41066
2026-10-29	NKTR	39.19	0.31	0.37	41159
2026-10-30	NKTR	38.87	0.31	0.90	41407
2026-11-02	NKTR	36.93	0.32	0.51	41751
2026-11-03	NKTR	37.8	0.32	0.03	42412
2026-11-04	NKTR	38.47	0.31	0.01	42753
2026-11-05	NKTR	36.12	0.31	0.83	43448
2026-11-06	NKTR	37.2	0.30	0.48	43324
2026-11-09	NKTR	37.78	0.29	1.59	43332
2026-11-10	NKTR	37.77	0.29	0.00	43269
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	NKTR	39.84	-15.9	-	-8.09
2026-10-13	NKTR	37.98	-15.9	-	-8.09
2026-10-14	NKTR	36.88	-15.9	-	-8.09
2026-10-15	NKTR	37.71	-15.9	-	-8.09
2026-10-16	NKTR	35.79	-12.9	-	-8.08
2026-10-19	NKTR	36.59	-12.9	-	-8.08
2026-10-20	NKTR	36.59	-12.9	-	-8.08
2026-10-21	NKTR	39.26	-12.9	-	-8.08
2026-10-22	NKTR	38.61	-12.9	-	-8.08
2026-10-23	NKTR	37.21	-12.9	-	-8.08
2026-10-26	NKTR	37.46	-12.9	-	-8.08
2026-10-27	NKTR	37.97	-12.9	-	-8.08
2026-10-28	NKTR	38.56	-12.9	-	-8.08
2026-10-29	NKTR	39.23	-12.9	-	-8.08
2026-10-30	NKTR	38.88	-12.9	-	-8.08
2026-11-02	NKTR	36.96	-12.9	-	-8.08
2026-11-03	NKTR	37.78	-12.9	-	-8.08
2026-11-04	NKTR	38.46	-12.9	-	-8.08
2026-11-05	NKTR	36.21	-12.9	-	-8.08
2026-11-06	NKTR	37.24	-12.9	-	-8.08
2026-11-09	NKTR	37.79	-12.9	-	-8.08
2026-11-10	NKTR	37.79	-12.9	-	-8.08
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	NKTR	-2.88	31.48	21.08
2026-10-13	NKTR	-2.88	31.48	21.08
2026-10-14	NKTR	-2.88	31.48	21.08
2026-10-15	NKTR	-2.88	31.48	21.08
2026-10-16	NKTR	-2.88	31.48	21.08
2026-10-19	NKTR	-2.88	30.15	21.08
2026-10-20	NKTR	-2.88	30.15	21.08
2026-10-21	NKTR	-2.88	30.15	21.08
2026-10-22	NKTR	-2.88	30.15	21.08
2026-10-23	NKTR	-2.88	30.15	21.08
2026-10-26	NKTR	-2.88	29.50	21.08
2026-10-27	NKTR	-2.88	29.50	21.17
2026-10-28	NKTR	-2.88	29.50	21.17
2026-10-29	NKTR	-2.88	29.50	21.17
2026-10-30	NKTR	-2.88	29.50	21.17
2026-11-02	NKTR	-2.88	29.76	21.17
2026-11-03	NKTR	-2.88	29.76	21.17
2026-11-05	NKTR	-2.88	29.76	21.17
2026-11-06	NKTR	-2.88	29.76	21.17
2026-11-09	NKTR	-2.88	28.94	21.17
2026-11-10	NKTR	-2.88	28.94	21.17
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.23

Avg. EPS Est. Current Quarter

-2.07

Avg. EPS Est. Next Quarter

-2.76

Insider Transactions

-2.88

Institutional Transactions

28.94

Beta

1.42

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

84.2

Max Drawdown 5-Year %

-97.3

Target Price

133.08

P/E

Forward P/E

PEG

P/S

23.63

P/B

1.43

P/Free Cash Flow

EPS

-6.7

Average EPS Est. Cur. Y

-8.08

EPS Next Y. (Est.)

-10.5

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-287.84

Relative Volume

0.36

Return on Equity vs Sector %

-43.7

Return on Equity vs Industry %

-24

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ NKTR Healthcare

$37.78

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

16/25

Volume

11/15

Valuation

12/20

TP/AR

1/10

Options

7/10

RSI

38.3

Range 1M

40.3%

Sup Dist

2.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

14/30

Estimates

2/20

Inst/Vol

5/15

Options

10/10

EPS Yr

16.9%

EPS NY

-30%

52W%

5.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +252.2% upside

Quality

6/30

Valuation

16/30

Growth

9/25

Stability

9/10

LT Trend

1/5

Upside

+252.2%

Quality

NKTR — P/E HistoricalBiotechnology

Nektar Therapeutics

Sector: Healthcare

Industry: Biotechnology

Employees: 63

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorporated in 1990 and is headquartered in San Francisco, California.

NKTR

Latest News

—

Caricamento notizie per NKTR…

stock quote shares NKTR – Nektar Therapeutics Stock Price stock today

news today NKTR – Nektar Therapeutics stock forecast ,stock prediction 2023 2024 2025

marketwatch NKTR – Nektar Therapeutics yahoo finance google finance

stock history NKTR – Nektar Therapeutics invest stock market

stock prices NKTR premarket after hours

ticker NKTR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NKTR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y